why choose us

First received: August 15, 2023

Clinical Trial: Induction Chemo-Nivo in Unresectable Stage III NSCLC

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung Cancer, Nonsmall Cell

Study Type: INTERVENTIONAL


Official Title: Phase II Study of Induction Platinum Doublet in Combination With Nivolumab Followed by Surgery or Concurrent Chemoradiation in Unresectable Stage IIIA-C Non-small Cell Lung Cancer (NSCLC)

Brief Summary: The purpose of this study is to determine the response rate, safety, and effectiveness of a combination therapy in patients with lung cancer.

Read more